Hydrophobic tag assisted peptide synthesis
Yusuke Kohno
CEO, Jitsubo
Jitsubo is a privately-held biopharmaceutical company employing hydrophobic tag assisted peptide synthesis technology platform. This technology integrates the advantages of both solution phase method and solid phase method and made it good hybrid. This unique characteristic enables to develop modified peptide derivatives which contain functional moiety on the arbitrary position to improve the pharmacological parameters. In this presentation, the advantages of manufacturing peptide API with this technology will be also demonstrated.